A major update to the American Society of Addiction Medicine's practice guideline for treating opioid use disorder includes the advice that unavailability or refusal of psychosocial treatment should not impede patient access to medication.
An analysis of a state's publicly funded treatment for opioid use disorder found a substantially lower overdose death risk for patients receiving medication treatment, with risk for all patients increasing post-treatment.
With the far reach of the opioid epidemic and the high comorbidity of opioid addiction with other psychiatric disorders, the session will be relevant to all attendees, not just those in addiction medicine.
During the opening plenary of NCAD West on Thursday, Colorado Consortium for Prescription Drug Abuse director Rober Valuck, PhD, RPh, FNAP, implored attendees to aggressively fight barriers to treatment, scrutinize their own work, and learn from their peers.
Las Vegas Recovery Center chief medical officer Mel Pohl, MD, DFASAM, shared risks of using opioids to treat chronic pain and offered non-medication alternatives to improve patients’ ability to function on Thursday at NCAD West.
SAN DIEGO—The opioid withdrawal drug lofexidine demonstrated statistically significant efficacy across a half-dozen patient- and clinician-reported outcomes during the first 7 days after immediate opioid cessation, according to study presented at…
SAN DIEGO—Prescribers who may be seeing an increase in patients with stimulant use disorders are still left relying on off-label treatment options with limited evidence of effectiveness, a researcher told a Psych Congress audience.
SAN DIEGO—Mental health clinicians will likely be taking on many more patients with opioid use disorder, as 40% of primary care providers will not accept any new patients who take opioids, an expert said at Psych Congress 2019.